These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9175986)

  • 1. Neuromuscular block in children.
    Fawcett WJ
    Br J Anaesth; 1997 May; 78(5):627. PubMed ID: 9175986
    [No Abstract]   [Full Text] [Related]  

  • 2. Shake Up in the Neostig- mine Methylsulfate Cholin- esterase Inhibitor Market for Neuromuscular Block Reversal.
    Welliver M
    AANA J; 2015 Aug; 83(4):240-2. PubMed ID: 26390739
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed reversal of a potentiated rocuronium neuromuscular block.
    Dubois PE
    Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Problem of neuromuscular block reversion: neostigmine and sugammadex].
    Mizikov VM; Stamov VI; Deshko IuV; Ialich AIu
    Anesteziol Reanimatol; 2010; (2):40-3. PubMed ID: 20524330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic doses of neostigmine, depolarising neuromuscular blockade and muscle weakness in awake volunteers: a double-blind, placebo-controlled, randomised volunteer study.
    Kent NB; Liang SS; Phillips S; Smith NA; Khandkar C; Eikermann M; Stewart PA
    Anaesthesia; 2018 Sep; 73(9):1079-1089. PubMed ID: 30132821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W; Reiner T; Khuenl-Brady KS
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
    Lien CA
    Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of calcium chloride coadministered with neostigmine on neuromuscular blockade recovery: A double-blind randomised study.
    Ju JW; Kim HC; Yoon S; Hong DM; Park HP
    Eur J Anaesthesiol; 2017 Sep; 34(9):617-622. PubMed ID: 28763316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational study on patterns of neuromuscular blockade reversal.
    Dubovoy T; Housey M; Devine S; Kheterpal S
    BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
    Nicholson WT; Sprung J; Jankowski CJ
    Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
    Fuchs-Buder T; Baumann C; De Guis J; Guerci P; Meistelman C
    Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
    Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
    [No Abstract]   [Full Text] [Related]  

  • 17. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it always necessary to antagonize residual neuromuscular block? Do children differ from adults?
    Hunter JM
    Br J Anaesth; 1996 Dec; 77(6):707-9. PubMed ID: 9014619
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of sugammadex on steroid hormones: A randomized clinical study.
    Gunduz Gul G; Ozer AB; Demirel I; Aksu A; Erhan OL
    J Clin Anesth; 2016 Nov; 34():62-7. PubMed ID: 27687347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
    Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
    Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.